Secondary Hyperparathyroidism

Secondary hyperparathyroidism is a condition where the parathyroid glands produce too much parathyroid hormone (PTH) in response to low calcium levels in the body. This usually happens because of problems with the kidneys or vitamin D metabolism, which affect calcium balance. The condition mainly impacts the bones and kidneys, leading to weak bones and potential kidney complications. It often occurs in people with chronic kidney disease, where the kidneys cannot maintain normal calcium and phosphate levels. The excess PTH tries to compensate by increasing calcium release from bones, which can cause bone pain and fractures. Overall, it disrupts the body's ability to keep calcium and phosphate in balance, affecting overall health.

Secondary hyperparathyroidism is characterized by an excessive secretion of parathyroid hormone (PTH) due to chronic hypocalcemia, typically caused by chronic kidney disease (CKD) or vitamin D deficiency. The underlying pathology involves impaired renal phosphate excretion and decreased synthesis of active vitamin D (1,25-dihydroxyvitamin D), leading to hypocalcemia and compensatory parathyroid hyperplasia. This condition results in increased bone resorption, contributing to renal osteodystrophy and increased fracture risk. It is distinct from primary hyperparathyroidism, as the parathyroid glands are responding appropriately to low calcium rather than autonomous overproduction. Clinically, patients may present with bone pain, muscle weakness, and vascular calcifications. Laboratory findings typically show elevated PTH, low or normal serum calcium, elevated serum phosphate, and low 1,25-dihydroxyvitamin D levels.